Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-05-28 @ 11:58 AM
Study NCT ID:
NCT03259867
Status:
RECRUITING
Last Update Posted:
2024-11-22
First Post:
2017-08-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of TATE and PD-1 Inhibitor in Liver Cancer
Sponsor:
Teclison Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LT-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None